Veronica Mollica - Concepedia

Author

Veronica Mollica

Also Known As

EAU Young Academic Urologists (YAU) Renal Cancer Working Group, Elisa Milan, Sebastiano Buti, Sindhura Chitikela, V MOLLICA, V. Mollica, VERONICA MOLLICA, Veronica MOLLICA, Veronica Mollica

285

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Azienda USL di Bologna Istituti di Ricovero e Cura a Carattere Scientifico Ospedale di Macerata Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori University of Parma

About

Veronica Mollica is an author at Azienda USL di Bologna specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	835
2	Public Health	1	1	30
3	Biostatistics	1	1	30
4	Cell Biology	1	1	19
5	Cellular Physiology	1	1	19

Veronica Mollica

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer Veronica Mollica, Alessandro Rizzo, Francesco Massari Future Oncology Coronavirus Disease 2019Viral PathogenesisPathologyVirologyPivotal Role	2020	174
The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study Veronica Mollica, Alessandro Rizzo, Andrea Marchetti, Clinical and Experimental Medicine Cancer ImmunosurveillanceMedicineImmunologyImmunoeditingImmune Checkpoint Inhibitor	2023	155
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience Giovanni Brandi, Alessandro Rizzo, Filippo Gustavo Dall’Olio, International Journal of Hyperthermia	2020	111
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials Francesco Massari, Alessandro Rizzo, Veronica Mollica, European Journal of Cancer UrologyCancer ImmunosurveillanceGenitourinary CancerMedicineImmunology	2021	99
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Therapeutic Advances in Medical Oncology	2021	86
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma Veronica Mollica, Matteo Santoni, Marc Matrana, Targeted Oncology UrologyOncologyPatients TreatedGenitourinary CancerPlus Ipilimumab	2021	75
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group? Matteo Santoni, Sebastiano Buti, Zin Myint, European Urology Oncology Differential EffectivenessUrologyGenitourinary CancerMedicineEpidemiology Of Cancer	2023	52
Peripheral nervous system adverse events associated with immune checkpoint inhibitors Simone Rossi, Francesco Gelsomino, Rita Rinaldi, Journal of Neurology	2023	42
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors Matteo Santoni, Francesco Massari, Sergio Bracarda, European Urology Focus UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorTyrosine Kinase Inhibitors	2022	36
Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study Francesco Massari, Vincenzo Di Nunno, Annalisa Guida, Clinical Genitourinary Cancer Neuro-oncologyUrologySurgical OncologyImdc CriteriaGenitourinary Cancer	2020	34

Page 1